| 摘要 |
<p>A description is given of new pharmaceutical compositions containing cyclosporine, combined with a carrier comprising at least a derivative of α-glycerophosphoric acid, such as α-glycerophosphorylcholine, α-glycerophosphorylserine, α-glycerophosphorylethanolamine and α-glycerophosphoryl-myo-inositol, which allow cyclosporine bioavailability to significantly increase.</p> |
